YD Bio (YDES) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on YD Bio (YDES) is Moderate Underperform.

The composite score behind that read is -0.21, weighing +0.11 of bullish evidence against -0.27 bearish.

YD Bio last closed at $8.11, +3.84% on the session.

Against the IVW growth benchmark the position is +2.92% over the forecast window.

The read is built from 11 underlying insights — 2 bullish and 9 bearish.

Agreement across those insights is 82%.

15 graded predictions for YDES so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

YD Bio is classified under Health Care / Biotechnology, with a market capitalisation of $574.54M.

StockMap tracks YD Bio as the 157th largest of the 344 companies it covers in the Biotechnology industry, part of the Health Care sector.

Across that group the current two-week reads are 180 Moderate Underperform, 152 Neutral, 11 Strong Underperform and 1 Moderate Outperform.

On that composite YD Bio ranks 179th of 344 in the group, against a group median of -0.21.